Related Experiment Videos
Just what the doctor ordered: avoiding kickback pitfalls with prescription drugs
1Wright, Morris & Arthur, LLP, 1919 Pennsylvania Avenue, NW, Suite 500, Washington, DC 20006-3434, USA. ssimmer@porterwright.com
Managed Care Interface
|February 7, 2002
Abstract:
Risks associated with the federal antikickback statute increased significantly for the pharmaceutical industry in the 1990s. Manufacturers, physicians, and MCOs must take account of the statute when developing programs that could possibly implicate it. This article provides guidance to the managed care community regarding legal kickback risks in arrangements with pharmaceutical manufacturers.